A controlled, open-label post-authorisation efficacy and safety study in imlifidase desensitised kidney transplant patients with

A controlled, open-label post-authorisation efficacy and safety study in imlifidase desensitised kidney transplant patients with positive crossmatch against a deceased donor prior to imlifidase treatment, including non-comparative registry and concurrent reference cohorts

Abierta

Código protocolo: 20-HMedIdeS-19
Código EudraCT: 2021-002640-70
Grupo de investigación: Nefrología y Trasplante Renal
Servicio: Nefrología
Investigador/a principal: Bestard Matamoros, Oriol
Patología: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
Fase: Fase III
Estado: Reclutando voluntarios